Influence of low penetrant factors on overall cancer risk
Influence of low penetrant factors on overall cancer risk
Links between EGFR/HER1 signalling and trastuzumab efficacy
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients
MLN9708 in combination with lenalidomide and dexamethasone
History of epidermal stem cell use in the clinical setting
Effects of obesity in breast cancer patients
The AZURE translational study
Diagnosis of blood cancer after a breast cancer diagnosis
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment
Cognitive problems may be present before chemotherapy in women with breast cancer